Physician profile
Ryan Flick
NPI 1962069872
$6,569.58
in general payments reported to CMS, 2019-2025
38 companies · $1,832 in 2025
The $1,832 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.16 · 2022: $397 · 2023: $2,191 · 2024: $2,135 · 2025: $1,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,138 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,137.86 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $813.20 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $666.72 | 2022-2025 | |
| Lilly USA, LLC | $642.64 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $598.01 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $457.12 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $373.76 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $369.63 | 2022-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $367.34 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $315.31 | 2023-2025 | Voquezna |
| Dexcom, INC. | $244.21 | 2022-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $167.16 | 2022-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Daiichi Sankyo INC. | $152.91 | 2022-2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.51 | 2022-2025 | Jardiance |
| Gilead Sciences, INC. | $123.14 | 2023-2024 | Veklury |
| Astellas Pharma US INC | $115.69 | 2022-2024 | Veozah, Myrbetriq |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.37 | 2024-2025 | Xifaxan, Trulance |
| Exact Sciences Corporation | $103.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Otsuka America Pharmaceutical, INC. | $78.70 | 2023-2024 | Rexulti, Nuedexta |
| Verona Pharma, INC. | $73.23 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $66.10 | 2020-2023 | Eliquis |
| Irhythm Technologies, INC. | $63.16 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $52.84 | 2023 | Dupixent |
| Organon LLC | $50.27 | 2022-2025 | Nexplanon |
| Stryker Corporation | $45.23 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Janssen Pharmaceuticals, INC | $42.40 | 2023 | Xarelto |
| Abiomed | $40.67 | 2025 | |
| Boston Scientific Corporation | $39.22 | 2024-2025 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $33.76 | 2023 | |
| Xeris Pharmaceuticals, INC. | $33.66 | 2025 | Gvoke Hypopen |
| Sequel Med Tech, LLC | $32.82 | 2025 | Twiist |
| Corcept Therapeutics | $31.27 | 2025 | Korlym |
| Inari Medical, INC. | $30.09 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $20.07 | 2025 | Nimbl, Flexitouch Plus |
| Abbott Laboratories | $19.59 | 2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $19.57 | 2025 | Zoryve |
| Electromed, INC. | $16.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.24 | 2023 | |
| Esperion Therapeutics, INC. | $14.96 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Flick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.